Comparison of low dose versus high dose Botulinum toxin (Dysport) in the treatment of children with hemiplegic cerebral palsy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN37525568

Enrollment

Registered

2004-01-23

Start date

1997-03-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous system diseases: Cerebral palsy Nervous System Diseases Cerebral palsy

Interventions

1. 24 ng Dysport/kg body weight 2. 8 ng Dysport/kg (using impairment measures)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with hemiplegic cerebral palsy

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Impairment measure using gait analysis 2. Gastrocnemius muscle length was calculated at each visit using the method described by Eames and used as primary outcome measure	—

Secondary

Measure	Time frame
Secondary outcome variable was maximum ankle angle measured during stance and swing phases.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026